Adverse events616

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 616

Type	Event	Organ system	Group	Affected	At risk
other	Abdominal pain	Gastrointestinal disorders	50 mg Dasatinib + 825 mg/m^2 Capecitabine	2	7
other	Abdominal pain	Gastrointestinal disorders	70 mg Dasatinib + 825 mg/m^2 Capecitabine	1	9
other	Abdominal pain	Gastrointestinal disorders	70 mg Dasatinib + 1000 mg/m^2 Capecitabine	0	6
other	Abdominal pain	Gastrointestinal disorders	100 mg Dasatinib + 1000 mg/m^2 Capecitabine	3	30
other	Dysgeusia	Nervous system disorders	50 mg Dasatinib + 825 mg/m^2 Capecitabine	1	7
other	Dysgeusia	Nervous system disorders	70 mg Dasatinib + 825 mg/m^2 Capecitabine	1	9
other	Dysgeusia	Nervous system disorders	70 mg Dasatinib + 1000 mg/m^2 Capecitabine	0	6
other	Dysgeusia	Nervous system disorders	100 mg Dasatinib + 1000 mg/m^2 Capecitabine	5	30
other	Dysphonia	Respiratory, thoracic and mediastinal disorders	50 mg Dasatinib + 825 mg/m^2 Capecitabine	1	7
other	Dysphonia	Respiratory, thoracic and mediastinal disorders	70 mg Dasatinib + 825 mg/m^2 Capecitabine	0	9
other	Dysphonia	Respiratory, thoracic and mediastinal disorders	70 mg Dasatinib + 1000 mg/m^2 Capecitabine	0	6
other	Dysphonia	Respiratory, thoracic and mediastinal disorders	100 mg Dasatinib + 1000 mg/m^2 Capecitabine	0	30
other	Eyelids pruritus	Eye disorders	50 mg Dasatinib + 825 mg/m^2 Capecitabine	0	7
other	Eyelids pruritus	Eye disorders	70 mg Dasatinib + 825 mg/m^2 Capecitabine	0	9
other	Eyelids pruritus	Eye disorders	70 mg Dasatinib + 1000 mg/m^2 Capecitabine	1	6
other	Eyelids pruritus	Eye disorders	100 mg Dasatinib + 1000 mg/m^2 Capecitabine	0	30
other	Haematuria	Renal and urinary disorders	50 mg Dasatinib + 825 mg/m^2 Capecitabine	0	7
other	Haematuria	Renal and urinary disorders	70 mg Dasatinib + 825 mg/m^2 Capecitabine	1	9
other	Haematuria	Renal and urinary disorders	70 mg Dasatinib + 1000 mg/m^2 Capecitabine	1	6
other	Haematuria	Renal and urinary disorders	100 mg Dasatinib + 1000 mg/m^2 Capecitabine	1	30

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00452673/events

API reference For AI assistants

Adverse events616

Sources 3

Read this list from software.